Download PDF
Horm Metab Res 2005; 37: 39-43
DOI: 10.1055/s-2005-861361
Review
© Georg Thieme Verlag KG Stuttgart · New York

Pericytes and the Pathogenesis of Diabetic Retinopathy

H.-P.  Hammes1
  • 1 5. Medical Department, University Hospital Mannheim, University of Heidelberg, Germany
Further Information

Publication History

Received 14 December 2004

Accepted after Revision 18 February 2005

Publication Date:
25 May 2005 (online)

Also available at
    Permissions and Reprints

Abstract

Incipient diabetic retinopathy is characterized by increased vascular permeability and progressive vascular occlusion. Pericyte loss precedes capillary occlusion in the diabetic retina, but its cause remains unclear. One concept proposes that pericyte loss is the result of toxic product accumulation and induction of destructive cellular signals generated within the pericyte. Alternatively, new experimental data indicate that pericyte dropout may result from regulations which induce pericyte elimination as an active process. Pericytes are critical for the development of a proper retinal network, and appear protective for endothelial cells under hyperglycemic conditions. The unifying hypothesis of hyperglycemia-induced microvascular damage centers around hyperglycemia-induced mitochondrial overproduction of reactive oxygen species. The pharmacological prevention of acellular capillaries without the rescue of pericyte loss in experimental diabetic retinopathy suggests that the endothelium is the primary therapeutic target.

Key words

Diabetic retinopathy - Pericytes - Microangiopathy - Capillaries

References

  • 1 Frank R N. Diabetic retinopathy.  N Engl J Med . Jan 1, 2004;  350 (1) 48-58
    PubMedSearch in Google Scholar
  • 2 Lindahl P, Johansson B R, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.  Science. 1997;  277 242-245
    CrossrefPubMedSearch in Google Scholar
  • 3 Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice.  Cytokine Growth Factor Rev. 2004;  15 (4) 215-228
    CrossrefPubMedSearch in Google Scholar
  • 4 Hohman T C, Nishimura C, Robison W G Jr. Aldose reductase and polyol in cultured pericytes of human retinal capillaries.  Exp Eye Res. 1989;  48 55-60
    CrossrefPubMedSearch in Google Scholar
  • 5 Stitt A W, Li Y M, Gardiner T A, Bucala R, Archer D B, Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.  Am J Pathol. 1997;  150 523-531
    PubMedSearch in Google Scholar
  • 6 Mizutani M, Kern T S, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.  J Clin Invest. 1996;  97 2883-2890
    CrossrefPubMedSearch in Google Scholar
  • 7 Hammes H P, Lin J, Wagner P, Feng Y, vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for. involvement in diabetic retinopathy.  Diabetes. 2004;  53 (4) 1104-1110
    CrossrefPubMedSearch in Google Scholar
  • 8 Allt G, Lawrenson J G. Pericytes: cell biology and pathology.  Cells Tissues Organs. 2001;  169 1-11
    CrossrefPubMedSearch in Google Scholar
  • 9 Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell and Tissue Research 2003 Jul 22
    Search in Google Scholar
  • 10 Jain R K. Molecular regulation of vessel maturation.  Nat Med. 2003;  9 (6) 685-693
    CrossrefPubMedSearch in Google Scholar
  • 11 Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom H C, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.  Genes Dev. 2003;  17 1835-1840
    CrossrefPubMedSearch in Google Scholar
  • 12 Hammes H P, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy.  Diabetes. 2002;  51 3107-3112
    CrossrefPubMedSearch in Google Scholar
  • 13 Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand S J, Yancopoulos G D, Nishikawa S. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.  J Clin Invest. 2002;  110 1619-1628
    CrossrefPubMedSearch in Google Scholar
  • 14 Cogan D, Toussaint D, Kuwabara T. Retinal vascular pattern. IV. Diabetic retinopathy.  Arch Ophthalmol. 1961;  66 366-378
    PubMedSearch in Google Scholar
  • 15 Little H L, Jack R L, Patz A P, Forsham P H, Ashton N. Pathogenesis of diabetic retinopathy. Diabetic Retinopathy. New York; Thieme-Stratton Inc 1983: 85-106
    Search in Google Scholar
  • 16 Engerman R L. Animal models of diabetic retinopathy.  Trans Am Acad Ophthalmol Otolaryngol. 1976;  81 OP710-715
    PubMedSearch in Google Scholar
  • 17 Hammes H P, Wellensiek B, Klöting I, Sickel E, Bretzel R G, Brownlee M B. The relationship of glycemic level to AGE accumulation and retinal pathology in the spontaneous diabetic hamster.  Diabetologia. 1998;  41 165-170
    CrossrefPubMedSearch in Google Scholar
  • 18 Hammes H P, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.  Proc Natl Acad Sci USA. 1991;  88 11 555-11 558
    PubMedSearch in Google Scholar
  • 19 Mansour S Z, Hatchell D L, Chandler D, Saloupis P, Hatchell M C. Reduction of basement membrane thickening in diabetic cat retina by sulindac.  Invest Ophthalmol Vis Sci. 1990 Mar 1;  31 (3) 457-463
    PubMedSearch in Google Scholar
  • 20 Enge M, Bjarnegård M, Gerhardt H, Gustafsson E, Kalén M, Asker N, Hammes H P, Shani M, Fässler R, Betsholtz C. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.  EMBO J. 2002;  21 4307-4316
    CrossrefPubMedSearch in Google Scholar
  • 21 Hellstrom M, Kalén M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.  Development. 1999;  126 3047-3055
    PubMedSearch in Google Scholar
  • 22 Sims D E. Diversity within pericytes.  Clin Exp Pharmacol Physiol. 2000;  27 842-846
    CrossrefPubMedSearch in Google Scholar
  • 23 Hellström M, Gerhardt H, Kalén M, Li X, Eriksson U, Wolburg H, Betsholtz C. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.  J Cell Biol. 2001;  153 543-553
    CrossrefPubMedSearch in Google Scholar
  • 24 Maisonpierre P C, Suri C, Jones P F, Bartunkova S, Wiegand S J, Radziejewski C, Compton D, McClain J, Aldrich T H, Papadopoulos N, Daly T J, Davis S, Sato T N, Yancopoulos G D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.  Science. 1997;  277 55-60
    CrossrefPubMedSearch in Google Scholar
  • 25 Brownlee M. Biochemistry and molecular cell biology of diabetic complications.  Nature. 2001;  414 813-820
    CrossrefPubMedSearch in Google Scholar
  • 26 Nishikawa T, Edelstein D, Du X L, Yamagishi S, Matsumara T, Kaneda Y, Yorek M, Beebe D, Oates P, Hammes H P, Giardino I, Brownlee M. Normalizing Mitochondrial Superoxide Production Blocks Three Major Pathways of Hyperglycemic Damage.  Nature. 2000;  404 787-790
    CrossrefPubMedSearch in Google Scholar
  • 27 Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.  J Clin Invest. 2003 Oct;  112 (7) 1049-1057
    CrossrefPubMedSearch in Google Scholar
  • 28 Hammes H P, Du X, Edelstein D, Taguchi T, Matsumara T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.  Nature Medicine. 2003;  9 294-299
    CrossrefPubMedSearch in Google Scholar

H.-P. Hammes, M. D.

5. Medical Department, University Hospital Mannheim

Theodor-Kutzer-Ufer 1 - 3 · 68167 Mannheim · Germany

Phone: +49 (621) 383 2663

Fax: +49 (621) 383 2663 ·

Email: hans-peter.hammes@med5.ma.uni-heidelberg.de